Is SANA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SANA. It does not provide personalized investment advice.

SANA (Sana Biotechnology, Inc. Common Stock) Stock Analysis - Financials

Sana Biotechnology, Inc. Common Stock (SANA) is a publicly traded Healthcare sector company. As of July 8, 2026, SANA trades at $3.95 with a market cap of $1.10B and a P/E ratio of -4.21. SANA moved -3.88% today. Year to date, SANA is +0.98%; over the trailing twelve months it is +32.90%. Its 52-week range spans $1.26 to $7.30. Analyst consensus is strong buy with an average price target of $9.80. Rallies surfaces SANA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SANA's key financials?

SANA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SANA recently traded at $3.95. Market cap is $1.10B. P/E ratio is -4.21. Revenue is $0.

SANA Key Metrics

Key financial metrics for SANA
Metric	Value
Price	$3.95
Market Cap	$1.10B
P/E Ratio	-4.21
EPS	$-0.96
Dividend Yield	0.00%
52-Week High	$7.30
52-Week Low	$1.26
Volume	1.50M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-244.17M
Gross Margin	0.00%

SANA Analyst Consensus

6 analysts cover SANA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.80.

Common questions about SANA

What are SANA's key financials?: SANA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SANA recently traded at $3.95. Market cap is $1.10B. P/E ratio is -4.21. Revenue is $0.
Is SANA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SANA. It does not provide personalized investment advice.